Valiant Compounding Pharmacy
- Pharmacy Profile Name: Valiant Compounding Pharmacy
- Website: valiantrx.com
- Location: 1274 Anna J Stepp Dr., Ypsilanti, Michigan 48197
- Founded: 2023
- Pharmacy Type: 503A compounding pharmacy
- Accreditations: LegitScript certified; PCCA member; A4PC affiliated
- GLP-1 Products: Compounded sublingual semaglutide, tirzepatide, and liraglutide
- Licensed States: All 50 U.S. states plus Puerto Rico and the U.S. Virgin Islands
- Telehealth Partners: Maintains a telehealth affiliate program; no named partners publicly disclosed
About the Pharmacy
Valiant Compounding Pharmacy was founded in 2023 with the sole purpose of providing the gold standard in pharmacy service to medical professionals and their patients. It is a 503A facility located in Ypsilanti, Michigan, serving patients and providers with competitive pricing, FedEx shipping, and fast turnaround time, guided by a resolute compliance team applying proven processes to compounding.
Despite being a newer entrant, founded just two years before the post-shortage GLP-1 regulatory tightening, Valiant has built a broad multi-state licensing footprint and established professional affiliations with major compounding raw material suppliers, including PCCA, Medisca, and Fagron.
GLP-1 Compounding
Valiant Compounding Pharmacy provides compounded sublingual (oral) options for semaglutide, tirzepatide, and liraglutide for weight management. The sublingual route allows the medication to be absorbed directly into the bloodstream through tissues under the tongue, bypassing the digestive system — an approach Valiant highlights as an alternative to injectable GLP-1 formulations.
Valiant adheres to USP 795 and USP 800 guidelines and uses high-quality ingredients sourced from FDA-registered facilities, leveraging what the pharmacy describes as cutting-edge technology to create medications tailored to healthcare providers’ exact specifications.
Compounded injectable semaglutide or tirzepatide is not listed among Valiant’s publicly described GLP-1 formulations as of March 2026; the pharmacy’s stated differentiator in the weight management space is its sublingual delivery format. Patients should confirm current GLP-1 formulation availability directly with the pharmacy, given the post-shortage regulatory environment.
Type of Pharmacy
Valiant Compounding Pharmacy is a 503A state-licensed compounding pharmacy. It holds LegitScript certification and is a PCCA member. No PCAB or NABP compounding accreditation was confirmed in public records as of March 2026. No FDA Warning Letter or enforcement action was found for Valiant Compounding Pharmacy as of March 2026.
States Licensed In
Valiant Compounding Pharmacy is currently licensed across all 50 U.S. states plus Puerto Rico and the U.S. Virgin Islands, making it one of the broader-reaching 503A pharmacies in this directory relative to its age. Medications are shipped via FedEx.
Telehealth Providers They Work With
Beyond direct collaboration with physicians to support their patients, Valiant partners with other healthcare professionals, including serving as the designated compounding pharmacy for healthcare systems, supplying placebos and medications for clinical trial research studies, and partnering with telehealth companies as their telehealth affiliate. No named telehealth partners are publicly disclosed on the pharmacy’s website. Valiant has a structured onboarding process for telehealth affiliate relationships and states that compliance with regulations, the practice of medicine, and pharmacy laws is a prerequisite for partnership.
Pricing from Reviews
No GLP-1-specific pricing is published on Valiant’s public-facing website. As a prescriber-facing compounding pharmacy, pricing is provided through the provider or patient inquiry process. The pharmacy positions itself on competitive pricing and fast FedEx turnaround.
Overall Reviews
Reviews of Valiant Compounding Pharmacy describe a customer-oriented pharmacy with friendly and efficient staff who ensure quick delivery of prescriptions, often arriving overnight even to customers outside Michigan. The commitment to service has earned a loyal clientele that appreciates attention to detail and responsiveness.
The pharmacy is relatively new (founded in 2023), so public review volume is limited compared to more established compounders. No patient safety complaints or adverse event reports were found in public records. The telemedicine affiliate program and broad 50-state licensing footprint suggest active growth in national telehealth fulfillment.





